Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
AIDS and Behavior
Published in: AIDS and Behavior 11/2014

01-11-2014 | Original Paper

Drug Use and Sexual Risk Among Gay and Bisexual Men Who Frequent Party Venues

Authors: Peter S. Theodore, Ron E. Durán, Michael H. Antoni

Published in: AIDS and Behavior | Issue 11/2014

Login to get access

Abstract

Research connecting club drug use to risky sex among gay/bisexual men (GBM) contains methodological issues that have limited knowledge about the relative risks of distinct drugs. This paper reports drug use and sexual behavior data from 197 GBM who frequented at least one party venue within 3 months of participating. Alarming rates of drug use and unprotected anal intercourse (UAI) with casual sex-partners were reported in connection with time spent at a bar, club or circuit party. Structural equation modeling revealed that use of methamphetamine, gammahydroxybutrate (GHB), and/or ketamine (K), but not use of ecstasy, at a party venue helped explain likelihood of UAI with a casual sex-partner while under the influence of a drug during/following time partying (β = 0.41, p < .01). Findings suggest use of methamphetamine, GHB and/or K at party venues increases risk for subsequent UAI with casual sex-partners. Study implications, limitations, and recommendations for future research are discussed.
Literature
1.
Chesney MA, Barrett DC, Stall R. Histories of substance use and risk behavior: precursors to HIV seroconversion in homosexual men. Am J Public Health. 1998;88:113–6.PubMedCrossRefPubMedCentral
2.
Fernandez MI, Bowen GS, Varga LM, et al. High rates of club drug use and risky sexual practices among Hispanic men who have sex with men in Miami. Florida. Subst Use Misuse. 2005;40:1347–62.CrossRef
3.
4.
Jerome RC, Halkitis PN, Siconolfi DE. Club drug use, sexual behavior, and HIV seroconversion: a qualitative study of motivations. Subst Use Misuse. 2009;44:431–47.PubMedCrossRef
5.
Koblin BA, Chesney MA, Husnik MJ, EXPLORE Study Team et al. High-risk behaviors among men who have sex with men in 6 US cities: baseline data from the EXPLORE Study. Am J Public Health. 2003;93:926–932
6.
Pappas MK, Halkitis PN. Sexual risk taking and club drug use across three age cohorts of HIV-positive gay and bisexual men in New York City. AIDS Care. 2011;23(11):1410–6.PubMedCrossRefPubMedCentral
7.
Shoptaw S, Frosch D. Substance abuse treatment as HIV prevention for men who have sex with men. AIDS Behav. 2000;4(2):193–203.CrossRef
8.
Stall R, Purcell DW. Intertwining epidemics: a review of research on substance use among men who have sex with men and its connectedness to the AIDS epidemic. AIDS Behav. 2000;4(2):181–92.CrossRef
9.
Bonell CP, Hickson FC, Weatherburn P, Reid DS. Methamphetamine use among gay men across the UK. Int J Drug Policy. 2010;21(3):244–6.PubMedCrossRef
10.
Halkitis PN, Mukherjee PP, Palamar JJ. Longitudinal modeling of methamphetamine use and sexual risk behaviors in gay and bisexual men. AIDS Behav. 2009;13:783–91.PubMedCrossRef
11.
Hirschfield S, Remien RH, Walavalkar I, Chiasson MA. Crystal methamphetamine use predicts incident STD infection among men who have sex with men recruited online: a nested case-control study. J Med Internet Res. 2004;6:41.CrossRef
12.
Shoptaw S, Reback CJ. Associations between methamphetamine use and HIV among men who have sex with men: a model for guiding public policy. J Urban Health. 2006;83(6):1151–7.PubMedCrossRefPubMedCentral
13.
Shoptaw S, Reback CJ, Peck JA, et al. Behavioral treatment approaches for methamphetamine dependence and HIV-related sexual risk behaviors among urban gay and bisexual men. Drug Alcohol Depend. 2005;78:125–34.PubMedCrossRef
14.
Kurtz SP. Post-circuit blues: motivations and consequences of crystal meth use among gay men in Miami. AIDS Behav. 2005;9(1):63–72.PubMedCrossRef
15.
Halkitis PN, Parsons JT, Stirratt MJ. A double epidemic: crystal methamphetamine drug use in relation to HIV transmission among gay men. J Homosex. 2001;41(2):17–35.PubMedCrossRef
16.
Carrico AW, Johnson MO, Moskowitz JT, et al. Affect regulation, stimulant use, and viral load among HIV-positive persons on anti-retroviral therapy. Psychosom Med. 2007;69(8):785–92.PubMedCrossRef
17.
Freese TE, Miotto K, Reback CJ. The effects and consequences of selected club drugs. J Subst Abuse Treat. 2002;23:151–6.PubMedCrossRef
18.
Tobias MC, O’Neill J, Hudkins M, Bartzokis G, Dean AC, London ED. White-matter abnormalities in brain during early abstinence from methamphetamine abuse. Psychopharmacol. 2010;209:13–24.CrossRef
19.
Halkitis PN, Palamar JJ. Mulitvariate modeling of club drug use initiation among gay and bisexual men. Subst Use Misuse. 2008;43:871–9.PubMedCrossRef
20.
Halkitis PN, Palamar JJ, Mukherjee PP. Poly-club-drug use among gay and bisexual men: a longitudinal analysis. Drug Alcohol Depend. 2007;89(2–3):153–60.PubMedCrossRefPubMedCentral
21.
Halkitis PN, Parsons JT. Recreational drug use and HIV-risk sexual behavior among men frequenting gay social venues. J Gay Lesbian Soc Serv. 2002;14(4):19–38.CrossRef
22.
Ramo DE, Grov C, Delucchi K, Kelly BC, Parsons JT. Typology of club drug use among young adults recruited using time-space sampling. Drug Alcohol Depend. 2010;107(2–3):119–27.PubMedCrossRefPubMedCentral
23.
24.
Lewis L, Ross M. A select body: the gay dance party subculture and the HIV/AIDS pandemic. New York: Cassell; 1995.
25.
Mansergh G, Colfax GN, Marks G, Rader M, Guzman R, Buchbinder S. The Circuit Party Men’s Health Survey: findings and implications for gay and bisexual men. Am J Public Health. 2001;91:953–8.PubMedCrossRefPubMedCentral
26.
Mattison AM, Ross MW, Wolfson T, Franklin D, HNRC Group. Circuit party attendance, club drug use, and unsafe sex in gay men. J Subst Abuse. 2001;13:119–126.
27.
Lee SJ, Galanter M, Dermatis H, McDowell D. Circuit parties and patterns of drug use in a subset of gay men. J Addict Dis. 2003;22(4):47–60.PubMedCrossRef
28.
29.
Ostrow DG. The role of drugs in the sexual lives of men who have sex with men: continuing barriers to researching this question. AIDS Behav. 2000;4(2):205–19.CrossRef
30.
Bux DA. The epidemiology of problem drinking in gay men and lesbians: a critical review. Clin Psychol Rev. 1996;16:277–98.CrossRef
31.
Kalichman SC, Tannenbaum L, Nachimson D. Personality and cognitive factors influencing substance use and sexual risk for HIV infection among gay and bisexual men. Psychol Addict Behav. 1998;12(4):262–71.CrossRef
32.
Leigh BC, Stall R. Substance use and risky sexual behavior for exposure to HIV: issues in methodology, interpretation, and prevention. Am Psychol. 1993;48:1035–45.PubMedCrossRefPubMedCentral
33.
Stueve A, O’Donnell LN, Duran R, San Doval A, Blome JR. Time-space sampling in minority communities: results with young latino men who have sex with men. Am J Public Health. 2001;91(6):922–6.PubMedCrossRefPubMedCentral
34.
Valleroy L, MacKeller DA, Karon JM, et al. HIV prevalence and associated risks in young men who have sex with men: young Men’s Survey study group. JAMA. 2000;284:198–204.PubMedCrossRef
35.
McElrath K, Chitwood DD, Griffin DK, Cornerford M. The consistency of self-reported HIV behavior among injection drug users. Am J Public Health. 1994;84(12):1965–70.PubMedCrossRefPubMedCentral
36.
Samuels JF, Vlahov D, Anthony JC, Chaisson RE. Measurement of HIV risk behaviors among intravenous drug users. Br J Addict. 1992;87:417–28.PubMedCrossRef
37.
Catania J, Gibson D, Chitwood D, Coates T. Methodological problems in AIDS behavioral research: influences on measurement error and participation bias in studies of sexual behavior. Psychol Bull. 1990;108:339–62.PubMedCrossRef
38.
Kalichman SC, Greenberg J, Abel GG. HIV-seropositive men who engage in high-risk sexual behavior: psychological characteristics and implications for prevention. AIDS Care. 1997;9(4):441–50.PubMedCrossRef
39.
Kauth MR, St. Lawrence JS, Kelly JA. Reliability of retrospective assessments of sexual HIV risk behavior: a comparison of biweekly, three month, and twelve month self-reports. AIDS Educ Prev. 1991;3:207–14.PubMed
40.
Winer BJ. Statistical principles in experimental design. New York: McGraw-Hill; 1971.
41.
Bollen KA, Bauldry S. Three C’s in measurement models: causal indicators, composite indicators and covariates. Psychol Methods. 2011;16(3): 265–284.
42.
Muthén LK, Muthén BO. Mplus User’s Guide. 6th ed. Los Angeles: Muthén and Muthén; 2010.
43.
Solomon TM, Halkitis PN, Moeller RW, Pappas MK. Levels of methamphetamine use and addiction among gay, bisexual, and other men who have sex with men. Addict Res Theory. 2012;20(1):21–9.CrossRef
44.
Parrott AC, Milani RM, Parmar R, Turner JD. Recreational ecstasy/MDMA and other drug users from the UK and Italy: psychiatric symptoms and psychobiological problems. Psychopharmocol. 2001;159:77–82.CrossRef
45.
Schilder AJ, Lampinen TM, Miller ML, Hogg RS. Crystal methamphetamine and ecstasy differ in relation to unsafe sex among young gay men. Can J Public Health. 2005;96(5):340–3.PubMed
46.
Maxwell JC, The Center For Excellence In Drug Epidemiology: The Gulf Coast Addiction Technology Transfer Center. Patterns of club drug use in the U.S., 2004: Ecstasy, GHB, ketamine, LSD, methamphetamine, rohypnol. The Center For Excellence In Drug Epidemiology: Austin; 2004.
47.
McElrath K. MDMA and sexual behavior: ecstasy users’ perceptions about sexuality and sexual risk. Subst Use Misuse. 2005;40(9):1461–77.PubMedCrossRef
48.
Bollen KA. Structural equations with latent variables. New York: Wiley; 1989.CrossRef
49.
Kline RB. Principles and practice of structural equation modeling. 3rd ed. Guilford Press: New York; 2011.
50.
Alvy LM, McKirnan DJ, Mansergh G, et al. Project Mix Study Group. Depression is associated with sexual risk among men who have sex with men, but is mediated by cognitive escape and self-efficacy. AIDS Behav. 2011;15:1171–1179.
51.
McKirnan DJ, Ostrow DG, Hope B. Sex, drugs and escape: a psychological model of HIV risk sexual behaviors. AIDS Care. 1996;8(6):655–69.PubMedCrossRef
52.
Kalichman SC, Johnson JR, Adair V, Rompa D, Multhauf K, Kelly JA. Sexual sensation seeking: scale development and predicting AIDS-risk behavior among homosexually active men. J Personal Assess. 1994;62(3):385–97.CrossRef
53.
Theodore PS, Achiro RP, Duran RE, Antoni MH. Body dissatisfaction and methamphetamine use among HIV-positive gay and bisexual men: a pilot study. Subst Use Misuse. 2011;46(14):1745–9.PubMedCrossRef
54.
Rawson RA, Gonzales RP, Pearce V, Ang A, Marinelli-Casey P, Brummer J. The methamphetamine treatment project corporate authors. Methamphetamine dependence and human immunodeficiency virus risk behavior. J Subst Abuse Treat. 2008;35(3):279–284.
55.
Shoptaw S, Reback CJ, Larkins S, et al. Outcomes using two tailored behavioral treatments for substance abuse in urban gay and bisexual men. J Subst Abuse Treat. 2008;35(3):285–93.PubMedCrossRef
56.
Miller WR, Rollnick S, editors. Motivational interviewing: preparing people to change addictive behavior. New York: Guilford Press; 1991.
57.
Morgenstern J, Bux DA, Parsons J, Hagman BT, Wainberg M, Irwin T. Randomized trial to reduce club drug use and HIV risk behaviors among men who have sex with men. J Consult Clin Psychol. 2009;77(4):645–56.PubMedCrossRefPubMedCentral
Metadata
Title
Drug Use and Sexual Risk Among Gay and Bisexual Men Who Frequent Party Venues
Authors
Peter S. Theodore
Ron E. Durán
Michael H. Antoni
Publication date
01-11-2014
Publisher
Springer US
Published in
AIDS and Behavior / Issue 11/2014
Print ISSN: 1090-7165
Electronic ISSN: 1573-3254
DOI
https://doi.org/10.1007/s10461-014-0779-y

Other articles of this Issue 11/2014

AIDS and Behavior 11/2014 Go to the issue

Commentary

Free Condom Distribution: What We Don’t Know May Hurt Us

Original Paper

A Systematic Review of Psychological Functioning of Children Exposed to HIV: Using Evidence to Plan for Tomorrow’s HIV Needs

Original Paper

Alcohol Use, Sexual Relationship Power, and Unprotected Sex Among Patrons in Bars and Taverns in Rural Areas of North West Province, South Africa

Original Paper

Beyond the Ball: Implications for HIV Risk and Prevention Among the Constructed Families of African American Men Who Have Sex with Men

Original Paper

Association of Supplemental Nutrition Assistance Program (SNAP) with Health Related Quality of Life and Disease State of HIV Infected Patients

Original Paper

Venues, Patrons, and Alcohol Use Dynamics: The Creation of a High Risk Sexual Environment
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits